Evaluation of inpatient pneumococcal vaccination rate among adult patients with diabetes in a tertiary care teaching hospital in Saudi Arabia

References

• Pneumococcal disease. World Health Organization. [online] Available from: http://www.who.int/ith/diseases/pneumococcal/en/ [Accessed 21 Jan. 2018]
   Google Scholar
• Kupronis BA, Richards CL Jr, Whitney CG. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc. 2003;51:1520–5. doi: 10.1046/j.1532-5415.2003.51501.x
   PubMed Web of Science ®Google Scholar
• World Population Prospects The 2015 Revision Key Findings and Advance Tables. 2015. [ebook] p.241. Available from: https://esa.un.org/unpd/wpp/publications/files/key_findings_wpp_2015.pdf [Accessed 20 Jan. 2018]
   Google Scholar
• Drijkoningen JJ, Rohde GG. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20(5):45–51. doi: 10.1111/1469-0691.12461
   PubMedGoogle Scholar
• Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med. 2013;369(2):155–63. doi: 10.1056/NEJMoa1209165
   PubMed Web of Science ®Google Scholar
• Robke JT, Woods M. A decade of experience with an inpatient pneumococcal vaccination program. Am J Health Syst Pharm. 2010;67(2):148–52. doi: 10.2146/ajhp080638
   PubMed Web of Science ®Google Scholar
• Myint T, Madhava H, Balmer P, Christopoulou D, Attal S, Menegas D, et al. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. Adv Ther. 2013;30(2):127–51. doi: 10.1007/s12325-013-0007-6
   PubMed Web of Science ®Google Scholar
• Moore M, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301–9. doi: 10.1016/S1473-3099(14)71081-3
   PubMed Web of Science ®Google Scholar
• Daniels C, Rogers P, Shelton C. A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens. J Pediatr Pharmacol Ther. 2016;21(1): 27–35.
   PubMedGoogle Scholar
• Black S, Lieu TA, Ray GT, Capra A, Shinefield HR. Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine. 2000;19(Suppl. 1):S83–6. doi: 10.1016/S0264-410X(00)00284-X
   PubMedGoogle Scholar
• Cho BH, Stoecker C, Link-Gelles R, Moore MR. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions. Vaccine. 2013;31(50):6011–21. doi: 10.1016/j.vaccine.2013.10.024
   PubMed Web of Science ®Google Scholar
• Nirmal J, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906–12. doi: 10.1056/NEJM199912163412507
   PubMed Web of Science ®Google Scholar
• Seminog O, Goldacre MJ. Risk of pneumonia and pneumococcal disease in people hospitalized with diabetes mellitus: English record-linkage studies. Diabet Med. 2013;30(12):1412–9. doi: 10.1111/dme.12260
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Rose Jr CE, Fry AM, Singleton JA., Moore Z, Zell ER, et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192:377–86. doi: 10.1086/431521
   PubMed Web of Science ®Google Scholar
• Pneumococcal Vaccine Recommendations. Centers for disease control and prevention. [online]. Available from: https://www.cdc.gov/vaccines. [Accessed 12 Jan. 2018].
   Google Scholar
• Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, Cheng AY. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diab. 2013;37(sup 1):S1–S3.
   PubMedGoogle Scholar
• American diabetes association standards of medical care in diabetes. Diabetes Care. 2017;40(sup 1):S1–S138.
   PubMedGoogle Scholar
• Al-Hajjaj MS, Alharbi NS, Zeitouni MO, Idrees MM, Al-Barrak AM, Al-Moamary MS, et al. The Saudi Thoracic Society pneumococcal vaccination guidelines-2016. Ann Thorac Med. 2016;11(2):93–102. doi: 10.4103/1817-1737.180030
   PubMed Web of Science ®Google Scholar
• Al-Nozha M, Al-Maatouq M, Al-Mazrou Y, Al-Harthi SS, Arafah MR, Khalil MZ, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004;25:1603–10.
   PubMed Web of Science ®Google Scholar
• Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med. 2011;31(1):19–23. doi: 10.5144/0256-4947.2011.19
   PubMed Web of Science ®Google Scholar
• Alsenany S, Al Saif A. Incidence of diabetes mellitus type 2 complications among Saudi adult patients at primary health care center. J Phys Ther Sci. 2015;27(6):1727–30. doi: 10.1589/jpts.27.1727
   PubMedGoogle Scholar
• Rubin DJ. Hospital readmission of patients with diabetes. Curr Diab Rep. 2015;15(4):504. doi: 10.1007/s11892-015-0584-7
   Web of Science ®Google Scholar
• Nowalk MP, Middleton DB, Zimmerman RK, Hess MM, Skledar SJ, Jacobs MA. Increasing pneumococcal vaccination rates among hospitalized patients. Infect Control Hosp Epidemiol. 2003;24(7):526–31. doi: 10.1086/502240
   PubMed Web of Science ®Google Scholar
• Smith JG, Metzger NL. Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital. J Manag Care Pharm. 2011;17(9):701–8.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, et al. Surveillance of vaccination coverage among adult populations—United States, 2015. MMWR Surveill Summ. 2017;66(11):1–28. doi: 10.15585/mmwr.ss6611a1
   PubMed Web of Science ®Google Scholar
• Wall GC, Van Der Veer JJ, Romine MJ, Yeager SM. Assessment of candidacy for pneumococcal vaccination in intensive care patients. Intensive Crit Care Nurs. 2013;29(4):212–5. doi: 10.1016/j.iccn.2012.10.004
   PubMed Web of Science ®Google Scholar
• Yang TU, Song JY, Noh JY, Cheong HJ, Kim WJ. Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea. Infect Chemother. 2015;47(1):41. doi: 10.3947/ic.2015.47.1.41
   PubMed Web of Science ®Google Scholar
• Brownfield E, Marsden JE, Iverson PJ, Zhao Y, Mauldin PD, Moran WP. Point of care experience with pneumococcal and influenza vaccine documentation among persons aged ≥65 years: high refusal rates and missing information. Am J Infect Control. 2012;40:672–4. doi: 10.1016/j.ajic.2011.12.006
   PubMed Web of Science ®Google Scholar
• Rees S, Stevens L, Drayton J, Engledow N, Sanders J. Improving inpatient pneumococcal and influenza vaccination rates. J Nurs Care Qual. 2011;26:358–63. doi: 10.1097/NCQ.0b013e31820e0e8c
   PubMed Web of Science ®Google Scholar
• Kishel JJ, Maguire M, Pankratz L, Julian K. Implementing an electronically based, nurse-driven pneumococcal vaccination protocol for inpatients. Am J Health Syst Pharm. 2009;66:1304–8. doi: 10.2146/080147
   PubMed Web of Science ®Google Scholar
• Fiks AG, Hunter KF, Localio AR, Grundmeier RW, Bryant-Stephens T, Luberti AA, et al. Impact of electronic health record-based alerts on influenza vaccination for children with asthma. Pediatr. 2009;124(1):159–69. doi: 10.1542/peds.2008-2823
   PubMed Web of Science ®Google Scholar
• Immunization, MOH. Kingdom of Saudi Arabia — Ministry of Health Portal. [online]. Available from: https://www.moh.gov.sa/en/eServices/Pages/VaccinationsDescription.aspx. [Accessed 20 Jan. 2018]
   Google Scholar
• Stockwell MS, Kharbanda EO, Martinez RA, Vargas CY, Vawdrey DK, Camargo S. Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial. JAMA. 2012;307(16):1702–8. doi: 10.1001/jama.2012.502
   PubMed Web of Science ®Google Scholar